What is the primary cause of spondylodiscitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Primary Cause of Spondylodiscitis

The primary cause of spondylodiscitis in adults is hematogenous spread of infection, with bacteria seeding the highly vascular vertebral endplates via septic emboli from bacteremia or endocarditis 1.

Pathophysiology of Infection

The mechanism follows a predictable pattern in adults:

  • Initial seeding occurs at the vertebral endplate through hematogenous spread, as the disc itself is avascular in adults
  • The infection then extends from the endplate into the adjacent intervertebral disc space
  • Subsequently spreads to involve the opposing vertebral body
  • Can further extend to posterior elements, paravertebral soft tissues, and epidural space 1

Most Significant Risk Factors

Bacteremia and endocarditis represent the most significant risk factors for developing spondylodiscitis 1. This explains why blood cultures are positive in approximately 47% of pyogenic spondylodiscitis cases 2.

Alternative (Less Common) Routes of Infection

While hematogenous spread dominates, spondylodiscitis can less commonly result from:

  • Direct extension from adjacent soft tissue infection
  • Direct inoculation during spinal procedures or penetrating trauma 1

These iatrogenic or traumatic causes are distinctly secondary mechanisms compared to the predominant hematogenous route.

Predominant Pathogen

Staphylococcus aureus is the leading causative organism, accounting for:

  • Up to 80% of pyogenic spondylodiscitis cases 3
  • 64% of pyogenic cases in recent series 2
  • Approximately half of all non-tuberculous cases 4

Worldwide, tuberculous spondylodiscitis remains the most common type globally, though pyogenic causes predominate in developed countries 5.

Distribution Pattern

The infection typically affects:

  • Single level involvement: 65% of patients
  • Multilevel contiguous infection: 20% of patients
  • Non-contiguous infection: 10% of patients 1

The lumbar spine is most frequently affected (63%), followed by thoracic (25%) and cervical (12%) regions 2.

Clinical Implication

Understanding that bacteremia/endocarditis drives most cases explains why identifying and treating the primary source of bacteremia is critical to successful management, and why blood cultures should be obtained before initiating antibiotics whenever possible 6, 2.

References

Research

Infectious spondylodiscitis: Epidemiology, diagnosis, microbiological findings, clinical features and outcomes in a 14-year retrospective study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025

Research

Spondylitis - Spondylodiscitis - an Update.

Zeitschrift fur Orthopadie und Unfallchirurgie, 2019

Research

Spondylodiscitis: update on diagnosis and management.

The Journal of antimicrobial chemotherapy, 2010

Research

Spondylodiscitis: Diagnosis and Treatment Options.

Deutsches Arzteblatt international, 2017

Related Questions

What oral treatment options are appropriate for spondylodiscitis after initial intravenous therapy?
What are the differences between vertebral osteomyelitis and spondylodiscitis?
In a hemodynamically stable, afebrile patient with Staphylococcus aureus spondylodiscitis who has received at least two weeks of intravenous therapy, has a declining C‑reactive protein, no persistent bacteremia, and an intact gastrointestinal tract, which oral antibiotics are recommended?
Is surgery or medication medically indicated for a patient with Spondylosis without myelopathy or radiculopathy in the lumbar region, who has undergone a procedure and has a history of lower back pain?
What is spondylodiscitis and how is it diagnosed and treated?
What is the appropriate treatment approach for a benign meningioma?
How should Poly‑Iron 150 Forte (150 mg elemental iron, 25 mg vitamin C, 1 mg folic acid) oral capsules be dosed in an adult patient without iron overload, hemochromatosis, active gastrointestinal bleeding, or hypersensitivity?
Which nutrients should be optimized or supplemented to prevent facial atrophy and achieve clinically significant improvement?
What does the term "white lung" refer to?
What is the appropriate pediatric dose of doxycycline for leptospirosis prophylaxis?
Can a nephrologist clear a 42‑year‑old woman with primary hepatic cholangiocarcinoma, rectal adenoma, pancreatic‑tail tumor, active lupus nephritis, systemic lupus erythematosus, scleroderma, inflammatory myopathy, and impaired renal function (serum creatinine 2.9 mg/dL) for treatment with capecitabine, atezolizumab, bevacizumab (Avastin), durvalumab (Imfinzi), and tremelimumab (Imjudo)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.